Close

Articles

The data-driven revolution: How real-time analytics are transforming mRNA manufacturing

After slow market growth following the first RNA therapy launch in 1998 , recent clinical and commercial successes have propelled RNA therapeutics into the pharmaceutical spotlight. RNA therapeutics now offer revolutionary treatments for many indications, from rare diseases to...

Enhancing patient outcomes through a robust data infrastructure strategy

Every step of the biopharmaceutical process generates data — from development to manufacture to distribution. Capturing and centralizing that data can help the industry create and deliver medicines and treatments more quickly and efficiently, ultimately improving patient care and...

Quality Assurance & Quality Control In The Pharma of Today!

The pharmaceutical industry is one of the most highly regulated sectors globally, and for good reason. From discovery to commercialization, developing a new drug is a complex process that involves multiple stages of research, development, and rigorous testing. Central...

Addressing research problems for the long term requires a data-centric strategy

In research and development (R&D), scientists are generating more data now than ever before. But finding success in today's digital age requires the implementation of a company-wide data-centric architecture that addresses research problems from a long-term perspective. How can we...

Holistic ADC Support: How CDMOs Can Help Navigate Bottlenecks of ADC Manufacturing

Antibody-drug conjugates (ADCs) are complex bioconjugates that combine a targeting antibody with a highly-potent payload using a linker molecule. This allows the delivery of nanomolar concentrations of a potent cytotoxic agent within a tumor (Figure 1). This targeted delivery...

QIAGEN’s role in advancing companion diagnostics for precision medicine

In the evolving landscape of healthcare, precision medicine has emerged as a game-changer, promising tailored treatments and improved patient outcomes. At the forefront of this revolution is QIAGEN, a global leader in Sample to Insight solutions, making significant strides...

Child-resistant packaging: navigating the delicate balance between security and inclusion

Within the highly regulated pharmaceutical industry, patient safety stands as an unwavering principle. Packaging design, in this context, assumes a critical role in safeguarding the well-being of individuals. Child-resistant closures, in particular, serve as a cornerstone in preventing accidental...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read